ElendiLabs — Regulatory consultancy platform connecting medical device and pharmaceutical manufacturers with verified experts worldwide
All regulatory hubs
Regulatory hub

Overview of the Ministry of Food and Drug Safety (MFDS) and Medical Device Regulation in South Korea

Learn about the role of MFDS in South Korea, the risk-based classification system for medical devices, and the mandatory KGMP and product registration requirements.

Overview

Summary of this regulator or jurisdiction and how it relates to market access.

Official regulator site

Ministry of Food and Drug Safety (MFDS) - Medical Device Regulation in South Korea

1. Overview of MFDS

The Ministry of Food and Drug Safety (MFDS) is the central regulatory authority in South Korea. Its mission is to promote public health by ensuring the safety, efficacy, and quality of medical devices, pharmaceuticals, and food products.

2. Regulatory Framework

The medical device sector is governed by the Medical Device Act (MDA). All devices must adhere to strict requirements for registration, manufacturing, and distribution.

3. Classification System

Devices are categorized into four classes based on risk:

  • Class I (Low Risk): Minimal potential for harm (e.g., stethoscopes, manual wheelchairs). Notification to NIDS is required.
  • Class II (Moderate Risk): Low potential risk (e.g., MRI, pulse oximeters). Requires certification or approval.
  • Class III (High Risk): Significant risk (e.g., respiratory apparatus, anesthesia systems). Requires MFDS approval.
  • Class IV (Very High Risk): Greatest potential risk (e.g., pacemakers, stents). Requires intensive MFDS approval.

4. Market Entry Requirements

To sell a device in South Korea, manufacturers must:

  1. Appoint a Korean License Holder (KLH): Mandatory for foreign entities.
  2. Obtain KGMP Certification: Compliance with Korean Good Manufacturing Practices.
  3. Product Registration: Submission of technical documentation and clinical data (for higher risk classes).

5. Post-Market Surveillance

MFDS monitors adverse events and tracks devices through the Unique Device Identification (UDI) system to ensure long-term safety.

Articles & guides

Insight articles mapped to this region on ElendiLabs.

Registration

August 16, 2025

Regulations on Unique Device Identification (UDI) Management in South Korea (MFDS Notice No. 2019-46)

A practical summary of South Korea’s MFDS UDI Management Regulations: what manufacturers/importers must register in the UDI system (UDI-DI, barcode standard, product and company data), optional fields, exemptions, how and when to register updates, confidentiality, and the phased enforcement timeline by device class.

Read article

Registration

August 11, 2025

Guidance on the Review and Approval of Artificial Intelligence (AI)-based Medical Devices in South Korea

South Korea’s MFDS guidance explains how AI-based medical devices should be reviewed for approval, emphasizing clear intended use, transparent algorithm and data documentation, robust verification/validation, clinically meaningful performance evidence, and lifecycle controls such as versioning and change management.

Read article

Registration

August 10, 2025

Guiding Principles for Conducting Clinical Trials for Machine Learning-enabled Medical Devices (MLMD) in South Korea (MFDS–HSA)

MFDS (Korea) and HSA (Singapore) jointly issued guiding principles (first released Dec 11, 2024) to address MLMD-specific clinical study challenges, covering trial design, dataset representativeness and independence, reference standards and adjudication, and endpoint analysis with justified acceptance criteria.

Read article

Registration

July 10, 2025

Regulation on the Permission, Notification, Review, Etc. of Medical Devices in South Korea (MFDS Public Notification No. 2022-52)

South Korea’s MFDS Public Notification No. 2022-52 details how to file manufacturing/import permission, certification, or notification for medical devices, how technical documents are reviewed (including staged review), and how to manage post-approval changes—forming a practical playbook for conformity assessment.

Read article

Registration

July 10, 2025

Approval Process for Medical Devices in South Korea (MFDS Overview)

An MFDS overview of South Korea’s premarket pathways (notification, certification, approval), the required technical documentation (including SER when clinical trial reports are needed), review timelines, business licensing for manufacturers/importers, and tracking-control obligations for high-risk devices.

Read article

Registration

June 11, 2025

Guidance on Clinical Trials Design of Artificial Intelligence (AI)-based Medical Devices in South Korea

South Korea’s guidance highlights how clinical trials for AI-based medical devices should address data quality, reference standards, workflow integration, and statistically sound performance evaluation to support regulatory submissions.

Read article

Registration

June 10, 2025

Guidance for Additional Considerations to Support Conformity Assessment of In Vitro Companion Diagnostic Medical Devices in South Korea

This guidance explains how South Korea expects in vitro companion diagnostics (IVD-CDx) to be developed, labelled, and supported with analytical and clinical performance evidence for conformity assessment—including scenarios such as follow-on tests, new specimen types, and class/group labelling.

Read article

Registration

March 10, 2025

Standards of Medical Device Good Manufacturing Practice (GMP) in South Korea (MFDS Notice No. 2023-31)

South Korea’s MFDS Notice No. 2023-31 consolidates the legal basis, scope, audit types, and operational procedures for medical device GMP (K-GMP), including who is subject to GMP audits, how audits are performed (document review vs. on-site), timelines for notifications, certificate validity, and rules for audit agencies and quality-manager training organizations.

Read article

Post Market Surveillance

July 7, 2024

South Korea License Maintenance: Monthly Supply Reporting and Amendment Requirements

License maintenance in South Korea requires manufacturers to report any license amendments to the MFDS and comply with mandatory monthly supply reports for all device classes (Class IV to I) via the integrated information system, excluding home-use devices.

Read article

Post Market Surveillance

June 10, 2024

South Korea Post-Market Surveillance (PMS): Tracking, Vigilance, and Penalties

An overview of South Korea's Post-Market Surveillance (PMS) requirements under the MFDS, covering mandatory tracking devices, adverse event reporting, and the severe administrative sanctions for non-compliance, including fines and license revocation.

Read article

Registration

May 14, 2024

South Korea Medical Device Labeling Requirements: MFDS Mandates and Korean Language Rule

Mandatory labeling for medical devices in South Korea is governed by the MFDS Medical Device Act. All labels, including the container and Instructions for Use (IFU), must be in Korean and contain specific identifiers like approval number, product name, and manufacturing data.

Read article

Registration

April 26, 2024

Mandatory Korea Good Manufacturing Practice (KGMP) Certification for South Korea Device Approval

KGMP certification is mandatory for Class II, III, and IV device registration in South Korea. The process, submitted by a local importer, involves either an MFDS document review or an on-site audit, with the certificate valid for three years.

Read article

Registration

March 1, 2024

South Korea IVD Registration: Risk Classification and Expedited Third-Party Review

An overview of the South Korean MFDS registration for In-Vitro Diagnostic (IVD) devices, highlighting the GHTF-aligned classification, the role of predicate devices (S.E.) in accessing expedited third-party review for Class II, and the Safety and Efficacy Review (SER) route.

Read article

Registration

February 26, 2024

South Korea Medical Device Registration: MFDS, KGMP, and the Substantial Equivalent Pathway

A guide to South Korea's medical device approval process via the MFDS, outlining the classification system, the requirement for Korean Good Manufacturing Practices (KGMP), and the expedited registration routes based on the existence of a Substantial Equivalent (S.E.).

Read article